FOR IMMEDIATE RELEASE | September 21, 2021

Jacob Hooker appointed editor-in-chief of ACS Chemical Neuroscience

WASHINGTON, Sept. 21, 2021 – The Publications Division of the American Chemical Society (ACS) welcomes Jacob Hooker, Ph.D., of the Massachusetts General Hospital (MGH) and Harvard Medical School as the editor-in-chief of ACS Chemical Neuroscience.

“I’ve been a proud part of the ACS Chemical Neuroscience community since the journal’s first issue, and as editor-in-chief, I plan to use the journal to inspire and unite,” says Hooker. “I will work to grow the journal’s community, expand opportunities for young scientists and connect with institutions focused on neuroscience globally. I look forward to continuing the journal’s tradition of excellence and will work to position ACS Chemical Neuroscience as the leading communicator in its field.”

Hooker is the Lurie Family professor of radiology in the field of autism research at Harvard Medical School and directs a thriving neuroimaging and chemical neuroscience program at the Martinos Center for Biomedical Imaging at MGH. He serves as scientific director of the Lurie Center for Autism, director of radiochemistry at the Martinos Center and director of translational biomarkers at the MGH Center for the Neuroscience of Psychedelics. He holds affiliate or associate appointments at the Massachusetts Institute of Technology, the Broad Institute and the Dana Farber Cancer Center. Hooker is the recipient of numerous awards, including a Presidential Early Career Award for Scientists and Engineers, and a Talented 12 Award from ACS’ Chemical & Engineering News. Hooker is a National Academy of Sciences Kavli Frontiers of Science fellow and has been named a distinguished investigator by the Academy for Radiology & Biomedical Imaging Research. Hooker completed his undergraduate degree at North Carolina State University and received a Ph.D. in chemistry from the University of California, Berkeley.

“I am delighted to welcome Professor Hooker to this position at ACS Chemical Neuroscience,” says James Milne, Ph.D., president, ACS Publications Division. “As the second editor-in-chief in the journal’s history, he has a unique opportunity to shape the future of the publication. I’m excited to work with Professor Hooker and see how his vision helps the journal reach even greater heights of excellence.”

ACS Chemical Neuroscience, established in 2010, publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological disorders. Hooker has been closely involved in the journal’s activities since its inception, having been one of the first authors published in the journal, publishing in it more than 30 times, and having served as an associate editor since 2013 and in the capacity of interim editor-in-chief since the beginning of 2021. 

Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.

Media Contact

ACS Newsroom
newsroom@acs.org